ProQR Therapeutics N.V. buy Raymond James
Start price
08.11.23
/
50%
€1.27
Target price
08.11.24
€3.75
Performance (%)
170.93%
End price
09.11.24
€3.43
Summary
This prediction ended on 09.11.24 with a price of €3.43. With a performance of 170.93% the BUY prediction by Raymond_James was a big success. Raymond_James has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| ProQR Therapeutics N.V. | 1.990% | 1.990% | -49.383% |
| iShares Core DAX® | 0,39 % | 0,15 % | 10,96 % |
| iShares Nasdaq 100 | 1,31 % | -2,55 % | -0,61 % |
| iShares Nikkei 225® | -0,46 % | 6,89 % | 26,75 % |
| iShares S&P 500 | 1,31 % | -1,16 % | -0,04 % |
Comments by Raymond_James for this prediction
In the thread ProQR Therapeutics N.V. diskutieren
ProQR Therapeutics (NASDAQ: PRQR) had its price target lowered by analysts at Raymond James from $5.00 to $4.00. They now have an "outperform" rating on the stock.
Ratings data for PRQR provided by MarketBeat
In the thread Trading ProQR Therapeutics N.V.
Die von Raymond_James gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Raymond_James for ProQR Therapeutics N.V.
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€3.19
29.10.24
29.10.24
€12.97
29.10.25
29.10.25
-30.89%
30.10.25
30.10.25
